ArticleEuropean journal of nuclear medicine and molecular imaging2011

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.

Rogier P J Schroeder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.